Pilot Study of Hyperfractionated Dosing of Lutetium‐177–Labeled Antiprostate‐Specific Membrane Antigen Monoclonal Antibody J591 ( 177 Lu‐J591) for Metastatic Castration‐Resistant Prostate Cancer
Oncologist - United States
doi 10.1634/theoncologist.2020-0028
Full Text
Open PDFAbstract
Available in full text
Date
January 30, 2020
Authors
Publisher
Alphamed Press